Fri, Mar. 18, 7:25 AM
- Eagle Pharmaceuticals (NASDAQ:EGRX) receives a Complete Response Letter (CRL) from the FDA regarding its New Drug Application (NDA) seeking clearance of KANGIO (bivalirudin injection), an intravenous formulation of 5 mg/mL bivalirudin for use as an anticoagulant in patients undergoing percutaneous coronary intervention (NYSE:PCI) (with the use of a glycoprotein IIb/IIIa inhibitor), patients undergoing PCI with or at risk of heparin-induced thrombocytopenia (low platelets) and thrombosis syndrome and patients with unstable angina undergoing percutaneous transluminal coronary angioplasty.
- A CRL means that, in the FDA's view, the application is not approvable in its present form. Specifically, the agency requested further characterization of bivalirudin-related substances in the drug product. The company remains committed to KANGIO, a ready-to-use formulation of The Medicines Company's Angiomax (bivalirudin), and will work closely with the FDA to address the deficiencies and clarify a path forward.
- Shares are down 16% premarket on modest volume.
- Previously: Eagle Pharma submits NDA for ready-to-use bivalirudin (May 20, 2015)
Sep. 2, 2015, 1:08 PM
- The Pimco High Income Fund (PHK -8.6%) cuts its monthly distribution by just under two cents to $0.10346. With the fund trading at about a 33% premium to NAV as of the close yesterday, there's plenty of room for investors to show disappointment.
- Look out below, warned SA's Value With A Catalyst in a particularly well-timed article in early April (PHK was then trading at a 65% premium to NAV). With a change in managers following Bill Gross' departure, the fund made a sizable reduction to leverage, and the author said a dividend cut would be a must. The fund is lower by about 30% since.
- Two other Pimco CEFs hiked payouts this month, the Pimco Dynamic Income Fund (PDI -0.1%) boosted by a penny to $0.22, and the Pimco Dynamic Credit Income Fund (PCI +1.5%) by just under a penny to $0.164.
Sep. 26, 2014, 11:49 AM
- Pimco's closed-end funds and ETFs are plunging in the wake of Bill Gross' exit to Janus: PHK -8.7%, PGP -8.5%, PTY -6.2%, PCN -4.2%, RCS -4.3%, PFL -3.6%, PFN -2.7%, PKO -2.5%, PDI -2.2%, PCI -1.4%, BOND -0.2%.
- "A lot of people bought into Pimco because of Bill Gross, who was the face of the organization, and so they’re shooting first and asking questions later,” says Motley Fool Asset Management CIO Bill Mann. "Investing is a personal business, and the market is saying it trusted Bill Gross.”
- Meanwhile, headlines indicate Dan Ivascyn, Pimco's (OTCQX:AZSEY, OTCPK:ALIZF) deputy chief investment officer, will succeed Gross and take over portfolio management; WSJ had written earlier this week that Ivasycn already was growing in popularity among Pimco investors, who had been putting more money into his fund even as they were pulling it from Gross’ fund.
Aug. 13, 2013, 12:44 PM
- Tumbling Treasury prices - with TLT carving out a new 52-week low today - are again hitting income favorites.
- Leading mREITs (REM -1.4%) lower are Invesco (IVR -3.3%), Annaly (NLY -2.3%), American Capital (AGNC -2%), and Western Asset (WMC -1.6%).
- A number of income CEFs not long ago were so much in favor they commanded large premiums to NAV. They're now at seemingly growing-by-the-day discounts. Among the movers today is the Pimco Dynamic Income Fund (PDI -1.4%) selling for $27.45 against yesterday's closing NAV of $30.23. Others include: PCI, PFN, and PFL.
- Still trading at premiums to NAV are the Pimco High Income Fund (PHK -0.9%) and the Pimco Corporate & Income Fund (PTY -1.1%).
- Municipals (MUB -0.6%) slip as well, hitting Muni CEFs: NXZ -0.9%, IIM -1.2%, VKQ -0.7%.
- Related ETFs: MORT, MORL, SUB, MUNI, PVI, PZA, SHM, TFI, VRD, HYD, ITM, MLN, PRB, SMB, GMMB, SMMU, RVNU, NY .
The Fund seeks current income with capital appreciation through investing in multiple fixed-income sectors in the global credit markets, including corporate debt, mortgage-related and other asset-backed securities. The Fund will normally invest at least 50
Industry: Closed-End Fund - Debt
Country: United States